MicroRNA‑199a/b‑5p inhibits endometrial cancer cell metastasis and invasion by targeting <em>FAM83B</em> in the epithelial‑to‑mesenchymal transition signaling pathway

Xiong,Hanzhen; Wang,Na; Chen,Hui; Zhang,Minfen; Lin,Qiongyan

doi:10.3892/mmr.2021.11943

MicroRNA‑199a/b‑5p inhibits endometrial cancer cell metastasis and invasion by targeting FAM83B in the epithelial‑to‑mesenchymal transition signaling pathway

Authors:
- Hanzhen Xiong
- Na Wang
- Hui Chen
- Minfen Zhang
- Qiongyan Lin
View Affiliations

Affiliations: Department of Pathology, Central Laboratory of The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China, Department of Gynecology and Obstetrics, Guangzhou Institute of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China
Published online on: February 26, 2021 https://doi.org/10.3892/mmr.2021.11943
Article Number: 304
Copyright: © Xiong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous study demonstrated the role of family with sequence similarity 83, member B (FAM83B) in endometrial cancer tumorigenesis and metastasis. FAM83B is involved in epithelial‑to‑mesenchymal transition (EMT). However, the regulatory network of EMT, which promotes endometrial cancer cell metastasis, involving microRNAs (miRNAs/miRs) and FAM83B, has not been elucidated. To investigate the potential mechanism underlying miR‑199a/b‑5p in endometrial cancer, the effect of miR‑199a/b‑5p and its targeted FAM83B gene on the biological behaviour of endometrial cancer cells was assessed. The Gene Expression Omnibus dataset analysis results revealed that the expression levels of 150 miRNAs in non‑cancerous endometrial tissues were upregulated compared with those in endometrial cancer tissues. TargetScan predicted that the nucleotides 672‑679 of FAM83B 3'‑untranslated region (UTR) were the target sites of miR‑199a/b‑5p. The differentially expressed miRNAs were enriched in several Kyoto Encyclopedia of Genes and Genomes pathways. Reverse transcription‑quantitative PCR analysis revealed that the expression levels of miR‑199a/b‑5p in the endometrial non‑cancerous cell lines were significantly upregulated compared with those in the six endometrial cancer cell lines. miR‑199a/b‑5p inhibited the EMT signaling pathway by regulating the expression levels of E‑cadherin, N‑cadherin, Snail, α‑smooth muscle actin, vimentin and Twist. This suggested that miR‑199a/b‑5p inhibited endometrial cancer cell proliferation and migration through the inhibition of the EMT signaling pathway. Furthermore, the nucleotides 672‑679 of the FAM83B 3'‑UTR were demonstrated to be the binding site of miR‑199a/b‑5p. These results suggested that miR‑199a/b‑5p inhibited endometrial cancer cell proliferation and metastasis by targeting the 3'‑UTR of FAM83B, which is involved in the EMT signaling pathway.

View Figures

View References

1	Morice P, Leary A, Creutzberg C, Abu-Rustum N and Darai E: Endometrial cancer. Lancet. 387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
2	Geng YH, Wang ZF, Jia YM, Zheng LY, Chen L, Liu DG, Li XH, Tian XX and Fang WG: Genetic polymorphisms in CDH1 are associated with endometrial carcinoma susceptibility among Chinese Han women. Oncol Lett. 16:6868–6878. 2018.PubMed/NCBI
3	Rodriguez AM, Schmeler KM and Kuo YF: Lack of improvement in survival rates for women under 50 with endometrial cancer, 2000–2011. J Cancer Res Clin Oncol. 142:783–793. 2016. View Article : Google Scholar : PubMed/NCBI
4	Zhang HH, Li R, Li YJ, Yu XX, Sun QN, Li AY and Kong Y: eIF4Erelated miR320a and miR3405p inhibit endometrial carcinoma cell metastatic capability by preventing TGF-β-1induced epithelial-mesenchymal transition. Oncol Rep. 43:447–460. 2020.PubMed/NCBI
5	Su J, Morgani SM, David CJ, Wang Q, Er EE, Huang YH, Basnet H, Zou Y, Shu W, Soni RK, et al: TGF-beta orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. 577:566–571. 2020. View Article : Google Scholar : PubMed/NCBI
6	Qureshi R, Arora H and Rizvi MA: EMT in cervical cancer: Its role in tumour progression and response to therapy. Cancer Lett. 356:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
7	Mutlu M, Raza U, Saatci O, Eyupoglu E, Yurdusev E and Sahin O: miR-200c: A versatile watchdog in cancer progression, EMT, and drug resistance. J Mol Med (Berl). 94:629–644. 2016. View Article : Google Scholar : PubMed/NCBI
8	Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS and Ewald AJ: E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 573:439–444. 2019. View Article : Google Scholar : PubMed/NCBI
9	Li CF, Chen JY, Ho YH, Hsu WH, Wu LC, Lan HY, Hsu DS, Tai SK, Chang YC and Yang MH: Snail-induced claudin-11 prompts collective migration for tumour progression. Nat Cell Biol. 21:251–262. 2019. View Article : Google Scholar : PubMed/NCBI
10	Shen CQ, Yan TT, Liu W, Zhu XQ, Tian XL, Fu XL, Hua R, Zhang JF, Huo YM, Liu DJ, et al: High expression of FAM83B predicts poor prognosis in patients with pancreatic ductal adenocarcinoma and correlates with cell cycle and cell proliferation. J Cancer. 8:3154–3165. 2017. View Article : Google Scholar : PubMed/NCBI
11	Zou Z, Ma T, He X, Zhou J, Ma H, Xie M, Liu Y, Lu D, Di S and Zhang Z: Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression. Cell Death Dis. 9:7172018. View Article : Google Scholar : PubMed/NCBI
12	Cipriano R, Graham J, Miskimen KL, Bryson BL, Bruntz RC, Scott SA, Brown HA, Stark GR and Jackson MW: FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest. 122:3197–3210. 2012. View Article : Google Scholar : PubMed/NCBI
13	Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA and Jackson MW: FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies. Oncotarget. 4:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
14	Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, et al: Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor. Oncol Lett. 15:1549–1558. 2018.PubMed/NCBI
15	Lin Q, Chen H, Zhang M, Xiong H and Jiang Q: Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Biomed Pharmacother. 115:1089392019. View Article : Google Scholar : PubMed/NCBI
16	Wang Q, Ye B, Wang P, Yao F, Zhang C and Yu G: Overview of microRNA-199a Regulation in Cancer. Cancer Manag Res. 11:10327–10335. 2019. View Article : Google Scholar : PubMed/NCBI
17	Ye H, Pang L, Wu Q, Zhu Y, Guo C, Deng Y and Zheng X: A critical role of mir-199a in the cell biological behaviors of colorectal cancer. Diagn Pathol. 10:652015. View Article : Google Scholar : PubMed/NCBI
18	Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F, Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling. Dig Dis Sci. 59:2163–2172. 2014. View Article : Google Scholar : PubMed/NCBI
19	Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G and Maciejewski R: Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer. 12:3692012. View Article : Google Scholar : PubMed/NCBI
20	Zhang HY, Li CH, Wang XC, Luo YQ, Cao XD and Chen JJ: MiR-199 inhibits EMT and invasion of hepatoma cells through inhibition of Snail expression. Eur Rev Med Pharmacol Sci. 23:7884–7891. 2019.PubMed/NCBI
21	Chu Y, Wang Y, Peng W, Xu L, Liu M, Li J, Hu X, Li Y, Zuo J and Ye Y: STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. Biochem Biophys Res Commun. 500:626–631. 2018. View Article : Google Scholar : PubMed/NCBI
22	Cai J, Zhang Y, Huang S, Yan M, Li J, Jin T and Bao S: MiR-100-5p, miR-199a-3p and miR-199b-5p induce autophagic death of endometrial carcinoma cell through targeting mTOR. Int J Clin Exp Pathol. 10:9262–9272. 2017.PubMed/NCBI
23	Wang Z, Monteiro CD, Jagodnik KM, Fernandez NF, Gundersen GW, Rouillard AD, Jenkins SL, Feldmann AS, Hu KS, McDermott MG, et al: Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat Commun. 7:128462016. View Article : Google Scholar : PubMed/NCBI
24	Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, Zhou J, Heng BC, Zou XH, Ouyang H, et al: Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 8:1892017. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Sorosky JI: Endometrial cancer. Obstet Gynecol. 120:383–397. 2012. View Article : Google Scholar : PubMed/NCBI
27	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
28	Zheng Y and Yang X, Wang C, Zhang S, Wang Z, Li M, Wang Y, Wang X and Yang X: HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway. Sci Rep. 10:35762020. View Article : Google Scholar : PubMed/NCBI
29	Grant S: FAM83A and FAM83B: Candidate oncogenes and TKI resistance mediators. J Clin Invest. 122:3048–3051. 2012. View Article : Google Scholar : PubMed/NCBI
30	Richtmann S, Wilkens D, Warth A, Lasitschka F, Winter H, Christopoulos P, Herth FJF, Muley T, Meister M and Schneider MA: FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC. Cancers (Basel). 11:6522019. View Article : Google Scholar
31	Chao CC, Wu PH, Huang HC, Chung HY, Chou YC, Cai BH and Kannagi R: Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer. FEBS Lett. 591:1902–1917. 2017. View Article : Google Scholar : PubMed/NCBI
32	Hwang S, Jeong JJ, Kim SH, Chung YJ, Song SY, Lee YJ and Rhee Y: Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors. Sci Rep. 8:120162018. View Article : Google Scholar : PubMed/NCBI
33	Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL and Weinberg RA: Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 351:aad36802016. View Article : Google Scholar : PubMed/NCBI
34	Hamilton G and Rath B: Mesenchymal-epithelial transition and circulating tumor cells in small cell lung cancer. Adv Exp Med Biol. 994:229–245. 2017. View Article : Google Scholar : PubMed/NCBI
35	Dongre A and Weinberg RA: New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019. View Article : Google Scholar : PubMed/NCBI
36	Wang ZC, Gao Q, Shi JY, Guo WJ, Yang LX, Liu XY, Liu LZ, Ma LJ, Duan M, Zhao YJ, et al: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition. Hepatology. 62:1201–1214. 2015. View Article : Google Scholar : PubMed/NCBI
37	Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang Y, Ma R, Jiang YH and Sun NF: MicroRNA-199b-5p attenuates TGF-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Br J Cancer. 117:233–244. 2017. View Article : Google Scholar : PubMed/NCBI